Skip to main content
Back
Watch Compare

MANGOCEUTICALS, INC.

Data quality: 100%
MGRX
Nasdaq Services Health Services
$0.34
$0.00 (0.00%)
Mkt Cap: 5.77 M
Price
$0.35
Mkt Cap
5.77 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -5.85 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-25.96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-118.05%
Below sector avg (-15.95%)
ROIC-81.47%
Net Margin-4526.76%
Op. Margin-3954.28%

Safety

Debt / Equity
N/A
Current Ratio0.74
Interest Coverage-174.20

Valuation

PE (TTM)
-0.28
Above sector avg (-1.17)
P/B Ratio0.37
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -0.3 -1.2
P/B 0.4 1.4
ROE % -118.1 -16.0
Net Margin % -4526.8 -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 — 360,057.76 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -25.96% Revenue Growth (3Y) -21.04%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 456,021.0 Net Income (TTM) -20.64 M
ROE -118.05% ROA -110.47%
Gross Margin 54.91% Operating Margin -3954.28%
Net Margin -4526.76% Free Cash Flow (TTM) -5.85 M
ROIC -81.47% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.74
Interest Coverage -174.20 Asset Turnover 0.02
Working Capital -206,052 Tangible Book Value -191,053
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.28 Forward P/E N/A
P/B Ratio 0.37 P/S Ratio 12.65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -101.41%
Market Cap 5.77 M Enterprise Value 5.29 M
Per Share
EPS (Diluted TTM) -2.17 Revenue / Share 0.03
FCF / Share -0.35 OCF / Share -0.35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 28.34%
SBC-Adj. FCF -7.16 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 456,021.0 615,873.0 731,493.0
Net Income -20.64 M -8.71 M -9.21 M
EPS (Diluted) -2.17 -4.84 -0.57
Gross Profit 250,386.0 379,964.0 431,501.0
Operating Income -18.03 M -7.97 M -9.22 M
EBITDA — — —
R&D Expenses — — —
SG&A Expenses — — —
D&A — 9,936.0 —
Interest Expense 103,513.0 -6,473.0 6,473.0
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 16.09 M 15.37 M 1.05 M
Total Liabilities 890,568.0 1.43 M 276,039.0
Shareholders' Equity 15.20 M 13.95 M 774,754.0
Total Debt — — —
Cash & Equivalents 1.49 M 58,653.0 739,006.0
Current Assets 1.55 M 75,595.0 818,460.0
Current Liabilities 890,568.0 1.43 M 211,078.0